- $299.80m
- $145.32m
- $38.63m
- 68
- 25
- 62
- 51
REG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - PDMR Dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Participation in Upcoming Investor Conference
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of Form 10-Q
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - First Quarter Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of AGM
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights and Block Listing Return
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options, RSUs and PSUs and PDMR Dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Grant of Options, RSUs and PSUs and PDMR Dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of form 10-K for FY ended December 31, 2023
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Reports Q4 & FY 2023 Financial Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
Announcement